Core Technology
The BioButton wearable device continuous monitoring solution is designed for proactive patient monitoring, collecting and analyzing the leading indicators of patient decline.
BioButton Wearable
Continuous vital sign and biometric measurements of patients both in facilities and at home
Flexible Gateways
Patient-facing BioMobile app, BioHub Cellular gateway, or BioHub Wi-Fi gateway
BioDashboard Analysis
and Display
Exception management software to monitor patients in-hospital and/or home
Smarter Monitoring. Better Outcomes.
Source: Churpek MM, Adhikari R, Edelson DP. The value of vital sign trends for detecting clinical deterioration on the wards. Resuscitation. 2016;102:1–5. doi:10.1016/j.resuscitation.2016.02.005
Improve Patient Safety
Studies show that comprehensive monitoring compared with standard, intermittent vitals reduce:
- Unplanned ICU admissions1-3
- Rapid response team activations1,3,4
- Average length of hospital stay5
Drive Operational Efficiency
With BioButton continuous monitoring data, patient stability insights can be leveraged to advance key hospital initiatives:
- Length of stay reduction efforts5
- Virtual rounding optimization
- Telemetry overuse reduction programs
Increase Patient and Nurse Satisfaction
With BioButton monitoring workflows in place, organizations can choose to alter their manual vital sign frequency. This can have the benefits of:
- Minimizing nighttime spot checks, improving patient restfulness
- Focusing nurse and staff attention on patients who most need care
The new standard in proactive monitoring for post-acute care
With the ability to transition monitoring seamlessly into the home, BioButton makes transitional care programs more convenient and connected for patients, while also:
- Enhancing facility length of stay reduction programs
- Preventing readmissions3
- Supporting RPM reimbursement
Interested in trying the BioButton?
We have demo opportunities to better understand our monitoring solution for your patients.
Recent News
BioIntelliSense Partners with Hicuity Health
The new partnership integrates the BioIntelliSense medical-grade BioButton® wearable and BioDashboard™ clinical intelligence solution with Hicuity Health’s robust patient monitoring services to scale virtual care programs from in-hospital to home….
Read more
BioIntelliSense Announces Observational Study in Journal of Clinical Medicine
The large-scale study of nearly 12,000 hospitalized patients highlights continuous multiparameter vital sign monitoring resulted in significant positive impact on patient outcomes BioIntelliSense, a continuous health monitoring and clinical intelligence…
Read more
BioIntelliSense Announces FDA Clearance of the BioButton® Multi-Patient Wearable and BioDashboard™
BioIntelliSense, a continuous health monitoring and clinical intelligence company, announces FDA clearance of the rechargeable BioButton® Multi-Patient wearable and BioDashboard™ system to cost-effectively grow and scale hospital virtual care programs….
Read moreReferences
- Eddahchouri Y, Peelen RV, Koeneman M, Touw HRW, van Goor H, Bredie SJH. Effect of continuous wireless vital sign monitoring on unplanned ICU admissions and rapid response team calls: a before-and-after study. Br J Anaesth. 2022;128(5):857-863.
- Verrillo SC, Cvach M, Hudson KW, Winters BD. Using Continuous Vital Sign Monitoring to Detect Early Deterioration in Adult Postoperative Inpatients. J Nurs Care Qual. 2019;34(2):107-113.
- Weller RS, Foard KL, Harwood TN. Evaluation of a wireless, portable, wearable multi-parameter vital signs monitor in hospitalized neurological and neurosurgical patients. J Clin Monit Comput. 2018;32(5):945-951
- Stellpflug C, Pierson L, Roloff D, et al. Continuous physiological monitoring improves patient outcomes. Am J Nurs. 2021;121(4):40–46.
- Sun L, Joshi M, Khan SN, Ashrafian H, Darzi A. Clinical impact of multiparameter continuous non-invasive monitoring in hospital wards: a systematic review and meta-analysis. J R Soc Med. 2020;113(6):217-224.
- Reduction realized at Houston Methodist Hospital with the adoption of a new vitals collection protocol in Jan 2024. Vitals collection requirement was reduced from Q4 to Q6 for patients with a BioButton.
- Weller GB, Mault J, Ventura ME, Adams J, Campbell FJ, Tremper KK. A Retrospective Observational Study of Continuous Wireless Vital Sign Monitoring via a Medical Grade Wearable Device on Hospitalized Floor Patients. J Clin Med. 2024 Aug 13;13(16):4747.
- 30-day readmission rate analysis of MA patients discharged from American Health Network, 2023.
- Earlier Activation of Clinical Emergency Response Team (CERT) After Implementing Vital Sign Remote Patient Monitoring: Mortality Impact on Those Transferred to ICU. January 2025: https://www.researchgate.net/publication/388385774_Earlier_Activation_of_Clinical_Emergency_Response_Team_CERT_After_Implementing_Vital_Sign_Remote_Patient_Monitoring